Patent Docs: The Law of Unintended Consequences Arises in Applying TRIPS to Patented Drug Protection in Developing Countries

Patent Docs: The Law of Unintended Consequences Arises in Applying TRIPS to Patented Drug Protection in Developing Countries: "In just the latest in a series of developments unwelcomed by Western drug companies, Brasil has threatened to distribute a generic version of Merck & Co.'s anti-AIDS drug efavirenz (Stocrin�). This action is consistent with earlier steps taken by Brasil, as well as Thailand, that thwart the intentions of the provisions of the TRIPS agreement regarding intellectual property protection, while paradoxically being in full compliance with WTO policies and practices."